Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy
Author:
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of Neoadjuvant Endocrine Therapy (Combined Androgen Blockade) on Normal Prostate and Prostatic CarcinomaAmerican Journal of Surgical Pathology, 1996
- Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic AdenocarcinomaAmerican Journal of Surgical Pathology, 1994
- Pathologic changes associated with androgen deprivation therapy for prostate cancerCancer, 1991
- Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on Normal Prostate and Prostatic AdenocarcinomaAmerican Journal of Surgical Pathology, 1991
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castrationThe Prostate, 1989
- Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: Today's therapy of choiceJournal of Steroid Biochemistry, 1988
- Cellular response to androgen depletion and repletion in the rat ventral prostate: Autoradiography and morphometric analysisThe Prostate, 1985
- Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulationPathology, 1984
- Reconsideration of Orchiectomy in the Treatment of Advanced Prostatic CarcinomaSouthern Medical Journal, 1977